Associations between safety and tolerability and reporting of health-related quality of life in phase III randomized trials in common solid tumors.

e19206Background: Anti-cancer drugs are approved typically on the basis of efficacy and safety as evaluated in phase III randomized trials (RCTs). Health related quality of life (HRQoL) is a direct...